Carl K Hoh

Optimization via specific fluorescence brightness of a receptor-targeted probe for optical imaging and positron emission tomography of sentinel lymph nodes

Zhengtao Qin, David J Hall, Michael A Liss, 2013, Journal of biomedical optics.

1-11C-Acetate Kinetics of Prostate Cancer

Johan Nuyts, Carl K Hoh, Sung-Cheng Huang, 2008, Journal of Nuclear Medicine.

Feasibility of atlas-based active bone marrow sparing intensity modulated radiation therapy for cervical cancer.

Rafal Tarnawski, Carl K Hoh, Umesh Mahantshetty, 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Correlation between radiation dose to ¹⁸F-FDG-PET defined active bone marrow subregions and acute hematologic toxicity in cervical cancer patients treated with chemoradiotherapy.

Carl K Hoh, Yun Liang, C. Hoh, 2011, International journal of radiation oncology, biology, physics.

Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry.

Carl K Hoh, David R Vera, Pascal Gallant, 2005, Nuclear medicine and biology.

Clinical use of FDG PET.

Carl K Hoh, C. Hoh, 2007, Nuclear medicine and biology.